Induction systemic therapy followed by surgery for stages II-III non-small cell lung cancer: steady efforts.
作者信息
Sekine Ikuo, Aida Yuka, Suzuki Hideo
机构信息
Department of Medical Oncology, Faculty of Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8575, Japan.
出版信息
J Thorac Dis. 2018 Nov;10(Suppl 33):S3942-S3945. doi: 10.21037/jtd.2018.09.91.
Abstract
摘要
相似文献
1
Induction systemic therapy followed by surgery for stages II-III non-small cell lung cancer: steady efforts.
J Thorac Dis. 2018 Nov;10(Suppl 33):S3942-S3945. doi: 10.21037/jtd.2018.09.91.
2
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Ann Thorac Surg. 1995 Sep;60(3):586-91; discussion 591-2. doi: 10.1016/0003-4975(95)00457-V.
3
The Outcomes of Induction Chemoradiotherapy Followed by Surgery for Clinical T3-4 Non-Small Cell Lung Cancer.
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819871327. doi: 10.1177/1533033819871327.
4
Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
Transl Lung Cancer Res. 2013 Oct;2(5):398-402. doi: 10.3978/j.issn.2218-6751.2013.10.07.
5
A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
Ann Surg. 1985 Sep;202(3):335-41. doi: 10.1097/00000658-198509000-00010.
6
Clinical studies in non-small cell lung cancer: the CALGB experience.
Cancer Invest. 1998;16(2):72-9. doi: 10.3109/07357909809039760.
7
Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
Semin Thorac Cardiovasc Surg. 2005 Fall;17(3):186-90. doi: 10.1053/j.semtcvs.2005.06.015.
8
Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer.
Am J Clin Oncol. 1999 Jun;22(3):237-42. doi: 10.1097/00000421-199906000-00005.
9
Induction therapy for early-stage non-small-cell lung cancer.
Oncology (Williston Park). 2004 Jul;18(8 Suppl 5):32-7.
10
Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.
Thorac Surg Clin. 2013 Aug;23(3):273-85. doi: 10.1016/j.thorsurg.2013.04.004. Epub 2013 May 17.
引用本文的文献
1
Endobronchial ultrasound: A novel screening test for pulmonary hypertension prior to major pulmonary surgery.
JTCVS Tech. 2023 Dec 15;23:146-153. doi: 10.1016/j.xjtc.2023.10.030. eCollection 2024 Feb.
2
Image-guided drug delivery of nanotheranostics for targeted lung cancer therapy.
Theranostics. 2022 May 13;12(9):4147-4162. doi: 10.7150/thno.72803. eCollection 2022.
本文引用的文献
1
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med. 2018 May 24;378(21):1976-1986. doi: 10.1056/NEJMoa1716078. Epub 2018 Apr 16.
2
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
3
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2018 Feb;105(2):418-424. doi: 10.1016/j.athoracsur.2017.08.052. Epub 2017 Dec 6.
4
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.
Cancer Discov. 2016 Dec;6(12):1382-1399. doi: 10.1158/2159-8290.CD-16-0577. Epub 2016 Sep 23.
5
Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2016 Sep;17(5):e157-e167. doi: 10.1016/j.cllc.2015.12.013. Epub 2016 Jan 11.
6
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Cochrane Database Syst Rev. 2015 Mar 2;2015(3):CD011430. doi: 10.1002/14651858.CD011430.
7
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
8
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data.
Lancet. 2014 May 3;383(9928):1561-71. doi: 10.1016/S0140-6736(13)62159-5. Epub 2014 Feb 25.
9
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.
J Clin Oncol. 2013 Sep 20;31(27):3320-6. doi: 10.1200/JCO.2013.51.1816. Epub 2013 Aug 26.
10
Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
J Clin Oncol. 2012 Jan 10;30(2):172-8. doi: 10.1200/JCO.2010.33.7089. Epub 2011 Nov 28.
Zotero 插件